Citadel Advisors’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
495,659
+429,477
| +649% | +$18.7M | ﹤0.01% | 918 |
|
|
2025
Q1 | $2.47M | Sell |
66,182
-6,542
| -9% | -$244K | ﹤0.01% | 2391 |
|
|
2024
Q4 | $3.29M | Buy |
+72,724
| New | +$3.29M | ﹤0.01% | 2143 |
|
|
2024
Q3 | – | Sell |
-116,318
| Closed | -$4.58M | – | 5762 |
|
|
2024
Q2 | $4.58M | Buy |
+116,318
| New | +$4.58M | ﹤0.01% | 1755 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6079 |
|
|
2023
Q4 | – | Sell |
-243,126
| Closed | -$5.18M | – | 5867 |
|
|
2023
Q3 | $5.18M | Buy |
+243,126
| New | +$5.18M | ﹤0.01% | 1589 |
|